Rocket Pharmaceuticals, Inc. Treasury Shares Acquired
Rocket Pharmaceuticals, Inc. (RCKT) reported Treasury Shares Acquired of 100.00 thousand shares for the 0-month period ending 2018-12-28, per its 10-Q filed 2019-11-08.
Discontinued › Shareholders' Equity
us-gaap:TreasuryStockSharesAcquired · last filed 2019-11-08
- 2018-12-28: Treasury Stock, Shares, Acquired 0 month 100.00K shares.
| Period end | Treasury Stock, Shares, Acquired 0 month |
|---|---|
| 2018-12-28 | 100.00K shares 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |